The amino acid residues critical for interaction between herpes simplex virus type 1 (HSV-1) glycoprotein C (gC-1) and cell surface heparan sulphate (HS) were localized to two separate regions within antigenic site II of this glycoprotein. These amino acids were Arg-143, Arg-145, Arg-147 and Thr-150 in one region and Gly-247 in the other. This conclusion is based on the following observations. (i) Monoclonal antibodies defining gC-1 antigenic site II, and not those reactive with antigenic site I, inhibited HSV-l-induced haemagglutination and virus binding to susceptible cells. (ii) A number of HSV-1 mar mutants, altered at these critical residues, were impaired in attachment to cells. (iii) Synthetic peptides, corresponding to these two regions inhibited virus attachment to cells and infectivity. In addition these peptides were found to agglutinate red blood cells. This agglutination was inhibited by soluble HS, and was prevented by the pretreatment of red blood cells with heparitinase suggesting that cell surface HS was a site of peptide binding. The same was observed with the polycationic substances neomycin and poly-L-lysine. In conclusion, we propose that the regions of gC-1 represented by the HS-binding peptides may form a functional site of a polycationic nature, active in attachment to the polyanionic glycosaminoglycan chain of cell surface HS.
Introduction
Attachment of a virus to specific cellular receptors is the first step in the cell entry process and one of the major determinants of cell and tissue tropism. Heparan sulphate (HS) proteoglycan, a ubiquitous and multifunctional constituent of cell plasma membranes and extracellular matrices has been identified as a receptor for herpes simplex virus types 1 and 2 (HSV-1 and -2) (WuDunn & Spear, 1989; Shieh et al., 1992) . Of at least 11 envelope glycoproteins encoded by HSV-1 (Roizman & Sears, 1990; Hutchinson et al., 1992a, b; Baines & Roizman, 1993) , two were identified as heparin-binding proteins: glycoproteins C (gC) and B (gB) (Herold et al., 1991) . Although gC is regarded as the principal virus attachment protein (Herold et al., 1991 , Svennerholm et al., 1991 , the nature of the initial binding of HSV-1 to cells is largely unknown and, for at least three reasons, intriguing. First, gC-negative (gC-) mutants of HSV-1 show a reduced but still significant level of attachment to cells (Langeland et al., 1990; Herold et al., 1991; Svennerholm et al., 1991) indicating that the functions of gC-1 in attachment can be replaced by other glycoprotein(s), most probably by gB (Herold et al., 1991) . Second, the chemically unrelated polycationic substances neomycin and poly-L-lysine are known to interfere with HSV attachment (Langeland et al., 1987 (Langeland et al., , 1988 (Langeland et al., , 1990 ) but the precise target site of their action has not yet been identified. Third, monoclonal antibodies (MAbs) and polyclonal anti-gC antibodies exhibited only moderate or low attachment inhibition activity, similar to that of antibodies to gD (Fuller & Spear, 1985) , a glycoprotein involved in a step of HSV attachment/penetration subsequent to that mediated by gC (Fuller & Lee, 1992) .
The possibility that initial interaction between HSV-1 and HS can be mediated by more than one viral glycoprotein (Herold et al., 1991) has complicated studies on their role in attachment. One consequence of this is that little is known about the structural determinants of gC-1 involved in binding to HS. We have circumvented this difficulty by developing a haemagglutination (HA) assay, dependent on binding of gC-1 to red blood cell (RBC) surface HS (Trybala et al., 1990 . Here we describe localization of a functional attachment determinant of HSV-1 gC by testing (i) HA and the cellbinding activities of mutant viruses carrying defined mutations in the gC-1 gene and (ii) the inhibition of these activities by synthetic peptides and a panel of MAbs reactive with specific regions of gC-1. Wu et al. (1990) and Marlin et al. (1985) respectively. Data concerning mar mutant 2762/B1C1 are from Bergstr6m et al. (1993) .
Methods
Cells, viruses' and MAbs. African green monkey kidney (GMK-AH1) cells were grown in Eagle's MEM supplemented with 2% calf serum, 0.05 % Primaton RT substance, 100 U of penicdlin per ml and 100 mg of streptomycin per ml. Baby hamster kidney (BHK) cells were grown in Glasgow MEM supplemented with 8 % calf serum, 8 % tryptose phosphate broth, 1 mM-L-glutamine and antibiotics. The HSV-1 strams used were F (Ejercito et al., 1968) , 2762 (Nilheden et al., 1983) , KOS 321, a plaque-purified isolate of wild-type strain KOS (Holland et al., 1983a) and its gC-mutant designated gC 101 (Holland et al., 1984) . Antigenic variants of strain KOS 321, resistant to neutralization by a single anti-gC-1 MAb (mar mutants), were those isolated and characterized by Marlin et al. (1985) . The isolation of mar mutant 2762/B1C1 was described previously (Bergstr6m et al., 1992) . The patterns of resistance of mar mutants to MAbs (Marlin et al., 1985) as well as the sites of mutation in gC (Wu et al., 1990; Bergstr6m et al., 1993) are summarized in Table 1 .
Of the MAbs with specificity for gC-1, those designated C1 to C13 were characterized m detail elsewhere (Marlin et al., 1985) whereas B1C1, C2H12 and B1E6 (an anti-gE MAb) were produced as described previously (Olofsson et al., 1983) . High IgG concentrations of MAb B 1C 1 and C2H 12 were obtained by growing the hybridoma cell line in dialysis tubing (Sj6gren-Jansson & Jeansson, 1985) . MAb preparations were treated with acid-washed kaolin before use in an HA inhibition (HI) assay. For cell culture experiments IgG was purified from MAb samples by affinity chromatography on Protein G Sepharose (Pharmacia). Bound antibody was eluted with a reverse flow of glycine-HC1 pH 2.8, and immediately neutralized with Tris-HC1 pH 8.0. Purified antibodies were centrifuged in a 10K centrifugal microconcentrator (Filtron) to concentrate IgG and to replace most of the elution buffer with PBS. The immunoglobulin concentration was determined by a standard immunodiffusion technique (Tago-Difugen kit). The reactivity of a particular MAb with KOS 321 and F strains was checked by ELISA as follows. Confluent monolayers of GMK-AH 1 cells in 96-well plates were infected with HSV-1 and when the c.p.e, was advanced, the cells were fixed with 0.25 % glutaraldehyde in PBS for 5 min at room temperature. The test was further carried out as previously described (Holland et al., 1983b) , except that o-phenylenediamine, dissolved in citrate buffer pH 4.5, was used as the substrate. Each MAb was tested at an IgG concentration of 10 IJg/ml, and the results are presented as the difference between Aa92 values obtained in virusinfected and non-infected cells.
Preparation of radiolabelled virus. Radiolabelled, extracellular virus was separated by the modification of a method described previously (Svennerholm et al., 1980) . Briefly, GMK-AHI cells in roller bottles were infected with strain KOS 321 at an m.o.i, of 3 p.f.u, per cell and the virus was allowed to adsorb for 3 h at 37 °C. The cells were then washed twice with Eagle's medium and incubated in 30 ml of fresh Eagle's medium supplemented with [3H]thymidine (40 IxCi/ml) for a further 48 h at 37 °C. Culture fluid containing extracellular virus (approximately 108 p.f.u./ml; HA titre 1:256) was then clarified by low-speed centrifugation and centrifuged at 15000g for 5 min. The supernatant (10 ml portions) was run through a Sepharose CL-2B (Pharmacia) column (125 mm length and 25mm inner diameter) equilibrated with Hanks" balanced salt solution, and the 5 ml fractions were tested for radioactivity, infectivity and HA. The first peak of radioactivity (9 x 105 to 1 x 106 c.p.m./ml) overlapped with peaks of virus infectivity (approximately 6 x 107 p.f.u./ml) and HA activity (titres 1:64 to 1: 128). The separated virus material was supplemented with 1% BSA and stored at -70 °C. When necessary the virus was concentrated by using a centrifugal microconcentrator with a 300K cutoff.
HA and HI assays. Both assays were carried out as described previously . MAb samples to be used in the HI test were adjusted with the HA diluent to contain 1 mg of IgG per ml and then mixed with an equal volume of 25 % suspension of acid-washed kaolin to remove non-specific inhibitors of HA. Following 30 min of agitation at room temperature, the kaolin was sedimented by centrifugatlon, and the supernatant (now diluted 1 : 2) was used in the HI test.
Attachment inhibition assay. Inhibition of HSV-1 attachment by synthetic peptides or polycations was tested as follows. GMK-AH1 cells in 24-well plates were washed with PBS and then pretreated with PBS containing 1% BSA (PBS-BSA) for 1 h at room temperature. The medium was then aspirated and 0-2 ml PBS BSA containing indicated concentrations of peptide was added. Following incubation for 30 rain at 4 °C, 20 gl of radiolabelled strain KOS 321 was added and after moderate shaking the plates were kept for adsorption in a stationary position for a further 2 h at 4 °C. The cells were then washed three times with PBS, lysed with 0.2 ml of PBS containing 5 % SDS, and finally transferred to scintillation vials.
InhiNtion of HSV-1 attachment by MAbs was assayed by the method of Fuller & Spear (1985) . Briefly, GMK-AH1 or BHK cells in 24-well plates were washed with PBS supplemented with 1% heat- inactivated fetal calf serum (FCS), 0-1% glucose (PBS GC) and 0.5 % BSA, and incubated with 1 ml of the same medium for 15 min at 4 °C. Five-hundred and sixty lal of affinity-purified MAb, adjusted with PBS-GC-BSA to contain 250 pg of IgG per ml, was mixed with 60 lal of radiolabelled KOS 321 (3"6 × 106 p.f.u.) and incubated for 1 h at room temperature. Portions of the mixture (150 gl) were then added in duplicate to GMK-AH1 or BHK cells and kept for attachment for 2 h at 4 °C. The rest of the procedure was as described for the assay of inhibition of HSV-1 attachment by synthetic peptides.
Purification ofgC-l, gC-1 was purified from the extract of BHK cells infected with the F strain of HSV-1 by immunoaffinity (MAb B1C1) chromatography as previously described (Olofsson et aL, 1983) .
Peptide syntheszs. Based on the sequence data for gC of HSV-1 (Frink et al., 1983) four 15-mer peptides corresponding to selected regions of antigenic sites I and II (Table 2) were synthesized by using Fmoc synthesis protocol (Chiron Mimotopes). Each peptide contained a free amino group and amlde group at its N and C terminus respectively. Peptides were dissolved in milli-Q water and the stocks (500 gM) were stored at -20 °C. The SP-4 peptide, showing incomplete solubility in water, was dissolved in 0.1% acetic acid, and the pH was adjusted with NaOH to 7.4 when the stock was diluted further for experiments.
Interactions of synthetic peptides and polycations with surface of RBCs.
Binding of synthetic peptides, neomycin (Sigma) and poly-Llysine (M r 3960; Sigma) to the RBC surface was tested as follows. Serial twofold dilutions of the compound in 50 pl of the HA diluent medium in 96-well, U-bottomed plates were mixed with an equal volume of a 0.4 % suspension of RBCs. The type of agglutination was observed following RBC sedimentation. The same experiment was repeated with HS (preparation C, 1.5 sulphate groups per disaccharide unit) included in the HA diluent medium (10 lag per ml) or with RBCs pretreated with 2 U of heparitinase (Sigma). HS was kindly provided by Ulf Lindahl (Uppsala University, Sweden). Heparitinase-treated RBCs were prepared as previously described .
Results

Mapping of a functional gC-1 attachment site with MAbs
A panel of defined anti-gC-1 MAbs were tested for their ability to inhibit HSV-1 HA and cell-binding activities. MAbs 1 to 3 and 4 to 10 (Table 3) define gC-1 antigenic site I (residues 307 to 373) and site II (residues 129 to 247), respectively (Marlin et aL, 1985; Wu et al., 1990; Sj6blom et al., 1992; Bergstr6m et al., 1993) . C10, C13
and B1C1 MAbs, all of which react with antigenic site II of gC-l, inhibited HA activity of the KOS 321 and F strains of HSV-1 as well as that of gC-1 purified from the F strain (Table 3) . Attachment of radiolabelled virus to cells was inhibited by all site II-defining MAbs tested albeit with markedly lower efficiency in GMK-AH1 cells compared to BHK (Table 4) , suggesting a higher capacity of GMK-AH1 cells to support gC-independent binding of HSV-1. MAb B1C1, the most efficient inhibitor of virus HA, was also the most effective MAb in preventing HSV-1 adsorption to both GMK-AH1 and BHK cells. Together, the inhibition of virus HA and cell-binding activities by the antigenic site II-defining MAbs indicated that the functional attachment determinant of gC-1 was located at its N-terminal half, partly or entirely within the structures of antigenic site II. All anti-gC MAbs used gave positive ELISA signals with both KOS 321 (Table  3) and F (not shown) strains indicating that any lack of the HI or attachment-inhibiting activities was not due to the inability of a particular MAb to recognize the virus.
Mapping of a functional gC-1 attachment site with mar mutants
Since MAbs specific for the antigenic site II inhibited virus binding to cells, we sought to examine whether mar mutants, selected by growth in the presence of these antibodies, were impaired in attachment. To this end, we studied the kinetics of attachment to BHK cells of mar mutant C10.1 and its wild-type parent KOS 321. gC-101, a gC-mutant of KOS 321, was used as a control. Mutant C10.1 showed a delay in adsorption similar to that of a gC-strain indicating that the gC-1 attachment functions in mar mutant C10.1 were impaired (Fig. 1) . Little or no or gC 101 ( I ) in 1 ml of the same medium was added. After the indicated time of virus adsorption at 4 °C, the cells were washed three times with Eagle's medium and 2 ml of a fresh Eagle's medium containing 1% fetal calf sermn was added. Following 2 h of incubation at 37 °C, 2 ml of Eagle's medium supplemented with 0"6 % pooled human gammaglobulin was added and the cells were further incubated at 37 °C for 36 to 48 h. The plaques were then immunostained and counted. Each point is the average of four individual determinations from two separate experiments.
difference was found among C10.1, KOS 321 and gC-101 viruses when attachment kinetics were studied in GMK-AH1 cells (data not shown) again suggesting the higher capacity of these cells compared to B H K ones to support gC-independent binding of HSV-1. Having determined that mar gC mutants may have a defect in attachment, we then screened a panel of 12 defined mar mutants for HA activity. The HA antigen Table 5 ) observed as a regular net of agglutinated RBCs at the bottom of the Uplate. M a r mutants C10.3 and C13.1 induced incomplete HA (denoted +) with some non-agglutinated, ring-forming erythrocytes. C10.1 virus showed no HA activity ( -) . was prepared from culture fluid of GMK-AH1 cells which are known to produce a high titre of extracellular HSV-1 . We paid attention not only to the HA titre but also to the ability of the virus to cause complete HA, which could reflect differences in the affinity of the mutants for the RBC receptor (Fig, 2 , Table 5 ). Mar mutant Cl0.1, which had already been found to be impaired in adsorption to BHK cells at a degree comparable to a gC-strain, showed no HA. Four additional viruses carrying mutations in antigenic site I1, i.e. Cl0.3, C7.1, C13.1 and 2762/B1C1, caused in-complete agglutination of RBCs irrespective of the virus concentration, observed as some non-agglutinated, ringforming cells (Fig. 2 , Table 5 ). All other mutants exhibited complete HA at a titre comparable to, or twoto fourfold lower than the parental KOS 321 strain. The infectious titres of mar mutants were far above the threshold value required for HA to occur indicating that the slight, or absence of, HA activity exhibited by mar mutants C7.1, C10.1, C10.3 and C13.1 was not caused by low concentration of the virus. An examination of amino acid substitutions (Table 1 ) in mar mutants with impaired HA/attachment activities or none, revealed the following. (i) Mutations disrupting the attachment site of gC-1 were localized to two separate segments of this glycoprotein corresponding to amino acids 143 to 150 (C7.1, C10.3, C13.1, B1C1) and residue 247 (C10.1). (ii) The nature of these mutations was substitution of neutral amino acids for positively charged arginine residues (C7.1, C10.3, C13.1), replacement of glycine by a negatively charged aspartate residue (C10.1) or a substitution of Ile for Thr at a potential N-glycosylation site at residue 150 (2762/ B1C1).
Effect of synthetic peptides on HSV-1 infectiviO' and adsorption to cells
If the above regions predicted with MAbs and mar mutants really are critical for HSV-1 attachment, synthetic peptides corresponding to these segments of gC-1 should interfere with HSV-1 attachment to and infection of permissive cells. With this rationale we synthesized several 15-mer peptides covering the predicted attachment domain(s) on gC-1 (Table 2 ). Peptide SP-1 represented an arginine-rich core of gC-1 antigenic site II encompassing amino acids 143 to 150, and SP-4 spanned another gC-I segment with possible involvement in attachment, i.e. the site of the mar mutation C10.1. SP-3, the peptide corresponding to the residues on the left flank of SP-1 was selected because these two segments of gC-1 contain internal Cys-127 and Cys-144 residues which according to Kikuchi et al. (1984) are likely to be linked in the gC molecule. Peptide SP-1X, a scrambled version of SP-1, SP-4C, a modified SP-4 with a substitution of Thr for Tyr, and SP-5, a peptide covering the site of the mar C2.1 mutation in antigenic site I of gC-1, were used as controls. In addition, since part of the predicted attachment determinant contained an argininerich segment, the polycationic substances neomycin and poly-L-lysine were included in some experiments for comparative purposes.
Peptides covering the predicted attachment determinant of gC-1, i.e. SP-1 and SP-4, were inhibitory to HSV-1 infection of GMK-AH1 cells (Fig. 3) . Peptide SP-4 exhibited a moderate effect only affecting virus infectivity by less than 50%. Peptide SP-I was more potent and its concentration reducing the number of plaques by 50 % was 22 ~tM. A similar effect was observed with three further samples of peptide SP-1 produced by using two different synthesis protocols (data not shown). SP-1X, a scrambled analogue of SP-1, did not inhibit HSV-1 infectivity. Peptide SP-1 showed no inhibition of virus infectivity when added 1 h after infection of GMK-AH1 cells with HSV-1 (data not shown) suggesting that the observed inhibitory effect was due to peptide interference with early events of HSV-cell interaction.
To verify this, we tested the effect of the synthetic peptides on HSV-1 attachment to GMK-AH1 cells. As in the infectivity experiment, peptides were added to GMK-AHI cells before addition of HSV-1 and were kept during the 2 h period of virus adsorption (Fig. 4a) . To verify how tight the peptide interaction was with the cell surface, some cell monolayers containing preadsorbed peptide were washed with PBS before addition of the virus (Fig. 4b) . Like polycationic substances, peptide SP-1 inhibited HSV-1 attachment to GMK cells and its concentration necessary to reduce virus attachment by 50 % was 8-7 gM. The SP-1X peptide, which did not inhibit HSV-1 infectivity, reduced virus at- tachment but only at the highest concentration tested (50 ~tM). This can be attributed to the different conditions under which attachment and infectivity assays were carried out (note that SP-1 was more active in the attachment assay than in the infectivity assay, by over twofold). SP-4 also inhibited virus binding to cells, This peptide was tested at a concentration of only 50 btM, and the inhibitory effect expressed as a percentage of virus attachment in the absence of peptide was 40. were 108-44_+ 1.78 and 104.68_+ 11-86 respectively (data not shown). When G M K -A H I cells, pretreated with peptides or polycations, were washed with PBS before addition of the virus, no inhibiting compounds other than SP-1 and poly-L-lysine maintained the inhibition of HSV attachment to cells (Fig. 4 b) .
Peptides SP-1 and SP-4 were also tested for their ability to inhibit H A by HSV-1 strains KOS 321 and F. SP-1 inhibited viral H A from a concentration of 0.1 laM, whereas the effect of SP-4 could not be examined owing to agglutination of RBCs induced by this peptide (data not shown).
Binding of the blocking peptides to cell surface HS
Having determined that synthetic peptides representing the predicted attachment determinant of gC-1 inhibited virus infectivity, attachment and H A activity, we attempted to define whether these effects were due to peptide-HS interaction. For this purpose we tested the binding of the peptide to the RBC surface both in the presence of soluble HS and after the treatment of RBCs with heparitinase. Similar approaches, based on experiments performed in cell cultures, were used to identify HS as a receptor for HSV (WuDunn & Spear, 1989) . We observed that SP-1, SP-4 and polycationic substances caused incomplete agglutination of mouse RBCs (Fig. 5 , rows A). Neomycin and SP-4 induced similar agglutination of RBCs at concentrations above 1.6 tag per ml. In contrast poly-L-lysine caused H A in the range 0.1 to 1.6 lag per ml and SP-1 exhibited weak agglutination at 0"05 to 0-1 lag per ml with classical prozone effects at higher concentrations. The evidence for the prozone effect was that HSV-1-induced H A was inhibited by both SP-1 and poly-L-lysine in the concentration range at which the prozone was observed (data not shown). In contrast, peptides SP-1X and SP-3 caused RBC agglutination at much higher concentrations whereas SP-5 and SP-4C exhibited no RBC agglutination. RBC agglutination induced by SP-1, SP-4, poly-L-lysine and neomycin was not found when HS was included in the diluent medium (10 lag per ml) or when mouse RBCs were pretreated with heparitinase (Fig. 5 , rows B and C) indicating that HS was a site of binding of peptides from the predicted gC-1 attachment determinant as well as a site of binding of polycationic substances neomycin and poly-L-lysine.
D i s c u s s i o n
Using a panel of anti-gC MAbs, mar viruses carrying specific mutations in the gC gene and synthetic peptides we attempted to localize a functional site on HSV-1 gC-1 involved in binding to cell surface HS. The summary of our results is presented in Fig. 6 . The amino acid residues critical for gC-mediated attachment of HSV-I to HS were localized to two separate regions of this glycoprotein, one including Arg-143, Arg-145, Arg-147 and Thr-150, and the other containing Gly-247. Since mutation at Thr-150 was found to be associated with the absence of N-linked glycan at position 148 (Bergstr6m et al., 1993) The N-linked glycan at position 148 is depicted, the silhouette mimics the van der Waal surface of a diantennary complex-type N-linked glycan and its size is adjusted to correspond to the distance between adjacent amino acids in the peptide linkage. The disulphide bonding is according to the report by Kikuchi et al. (1984) .
C10 (Wu et al., 1990) , and therefore are likely to be located in close proximity in the three-dimensional structure of glycoprotein, forming a single attachment determinant. In addition, residues adjacent to these two regions were reported to contribute to the binding of the C3b component of complement further emphasizing the association between these two stretches in the native gC-1 (Hung et al., 1992) , A striking feature of the suggested attachment site is that it is of polycationic nature since part of it contains an arginine-rich segment. In accordance, polycationic substances such as neomycin, poly-L-lysine and polyarginine are known to compete with HSV attachment to the cells (Langeland et al., 1987 (Langeland et al., , 1988 (Langeland et al., , 1990 WuDunn & Spear, 1989~ Campadelli-Fiume et al., 1990 . Our observation that these substances can bind to cell surface HS suggested that gC-HS interaction relies to a large extent on ionic interaction. One important question is how simple ionic interactions may account for a high degree of specificity usually associated with the binding between the virus attachment protein and its receptor. Synthetic peptide SP-1 comprising the arginine-rich segment bound specifically and irreversibly to cell surface HS. SP-1X, a control peptide with the same net positive charge as SP-1, was inactive or exhibited significantly lower activity in the attachment assays further emphasizing the high specificity of interaction between SP-1 and HS. In contrast, SP-4 bound reversibly to HS whereas synthetic peptides corresponding to other regions of gC-1 bound weakly or not at all to HS even if some of them contained, like SP-1X, basic amino acid residues. This showed that the presence of basic amino acids per se is not sufficient to generate an irreversible, high affinity binding to HS; the topological distribution of such amino acids must be a critical parameter.
Since the HS glycosaminoglycan chain is built up of repetitive units it would be expected that the binding motif should be a regular structure of high order. Indeed, arginine residues in the irreversibly binding peptide are arranged in this way, forming a motif 137-RxxxRCRFRxxxR-151 with three critical arginines in the centre separated by hydrophobic amino acids. In our preliminary studies we found that the substitution of either histidine or threonine for F-146 drastically reduced the affinity of SP-1 for HS (E. Trybala, unpublished results) suggesting that the proper arrangement of arginines and hydrophobic residues might be necessary for specific spatial interaction with the negatively charged sulphate esters or carboxylic acid groups on the glycosaminoglycan chain of HS. This is in line with recent reports where consensus sequences, containing clusters of basic amino acids, have been proposed as heparin-binding determinants for a number of biologically active ligands (for review see Jackson et al., 1991) . In addition, comparison of the gC-1 amino acid sequence with its bovine herpesvirus type 1 (BHV-1) and pseudorabies virus (PRV) counterparts, gIII, revealed the existence of similar peptide stretches 177-RVGRFR-182 and 136-RRGRFR-141 for BHV-1 (Fitzpatrick et al., 1989) and PRV (Robbins et al., 1986) respectively with phenylalanine at a similar location.
By using PRV mutants with defined deletions in the gIII gene, Flynn et al. (1993) demonstrated that the functional attachment site of that molecule was located at its one-third N-terminal portion (amino acids 25 to 157). On the other hand, Liang et al. (1993) , using a panel of partially overlapping BHV-1 and PRV gIII peptides, identified multiple heparin-binding sites on these molecules. The majority of these heparin-binding peptides inhibited neither virus attachment to cells nor infectivity, and the only peptide effective with PRV (Liang et al., 1993) corresponded to the gIII segment located 100 amino acids downstream from the region predicted to contain the attachment site (Flynn et al., 1993) . This indicates that the ability of a particular peptide to interact with heparin does not necessarily imply that it has a biological function. Indeed, some residual activity associated with our control peptide SP-1X indicates that there may be some level of non-specific peptide-HS interactions. In addition, it should be taken into account that HS is one of the strongest polyanions in the mammalian organism and may interact in a more or less specific manner with a variety of polycationic substances.
The function of the other part of the HS-binding site of gC-1 encompassing Gly-247 seems to be more complex. On the one hand, SP-4, a synthetic peptide representing this region, bound to HS with significantly lower affinity than SP-1, and consequently gave only a moderate inhibition of HSV-1 attachment and infectivity. In fact, this peptide contained only two basic amino acids, i.e. arginine and histidine, located in an environment of aspartate and glutamate. SP-4, however, comprised several aromatic residues including tryptophan which was recently proposed to be required for binding of some peptides from the human thrombospondin type I repeats to heparin (Guo et al., 1992) . On the other hand, the C10.1 mutant with the mar phenotype defined by a substitution of Asp for Gly-247 completely lacked the ability to bind to HS via gC-1 which is in sharp contrast to the weaker effect of mutations in the arginine-rich region. It is reasonable to assume that it was not an elimination of Gly-247 per se, but the introduction of an aspartate residue into its position, which was responsible for the lack of HSbinding activity in HSV-1 mar mutant C10.1. As mentioned above, gC-1 polypeptide stretches comprising Gly-247 and the Arg-143 to Arg-147 segment are likely to be structurally, antigenically and functionally connected. Consequently the negative charge of the Asp-247 side-chain may abolish the affinity of arginine residues for HS. It is also noteworthy that this substitution of Asp for Gly has a profound effect on antigenic properties of mar mutant CI0. I since this virus lost reactivity with all MAbs defining antigenic site II of gC-1 (Marlin et al., 
19853.
Apart from the attachment function, gC-1 acts also as a receptor for the C3b component of complement (Friedman et al., 1984) . It is likely that the functional domains responsible for these two binding activities are not identical. First, binding of complement was inhibited by MAbs specific for both antigenic sites I and I1 (Friedman et al., 1986) , whereas a pattern of HI and attachment inhibition was restricted to the MAbs defining site II. Second, expression of C3b-binding activity by particular mar gC mutants (Friedman et al., 1986 ) differed from their HA activity presented in this paper. Finally, of the four regions identified as important for C3b-binding (Hung et aL, 19923 only segment IV, located between residues 223 and 246, partly overlapped with our HS-binding SP-4 peptide from the site of the mar C10.1 mutation. In contrast, SP-3, corresponding to residues 122 to 136, i.e. a gC-1 segment that was almost identical with region I contributing to C3b binding (Hung et al., 1992) , had little or no HS-binding ability.
Finally, although we cannot rule out a possibility that some other regions of gC-1 may contribute to the formation of a functional HSV-1 attachment site, the results of our experiments with MAbs, mar mutants, and synthetic peptides indicate that the two regions of gC-1 form a functional domain involved in binding to cell surface HS. Owing to the polycationic nature of this site, it appears that HSV-1 may mimic the way in which other biologically important ligands interact with HS. We are currently examining variants of the parent peptide SP-1 to localize the minimum sequence sufficient for HS binding, and to understand the nature of the irreversible interaction between this peptide and HS.
